Business
Grant of US Patent
Grant of US Patent.
About this update from Cambridge Nutritional Sciences Plc
[{"type":"text","content":"\n \nRNS Number : 9388C Omega Diagnostics Group PLC 23 April 2013 \n \n\n\nOmega Diagnostics Group PLC\n(\"Omega\" or the \"Company\")\n \nGrant of US Patent\n \nOmega (AIM: ODX), the medical diagnostics company focused on allergy, food intolerance and infectious disease, announces that it has been informed by the Burnet Institute that its exclusively licensed CD4 test for monitoring HIV-positive patients has been awarded a US Patent. The patent was granted on 2 April 2013 under number US 8,409,818 B2. The grant of this US patent widens the protection from territories where patents have already been granted in South Africa and the member states of the African Intellectual Property Organisation, and with patents pending in many other territories.\n \nCommenting on the patent grant, Andrew Shepherd, CEO of Omega said: \"We are delighted to learn of this US Patent award, extending the patent protection which already exists for our novel CD4 point-of-care test, and which is testimony to the years of hard work done by our colleagues at the Burnet Institute in partnership with others.\"\n \nContacts:\n \n\n\n\n\nOmega Diagnostics Group PLC \n\n\nTel: 01259 763 030\n\n\n\n\nAndrew Shepherd, Chief Executive\n\n\nwww.omegadiagnostics.com\n\n\n\n\nKieron Harbinson, Group Finance Director\n\n\n\n\n\n\n\nJag Grewal, Group Sales and Marketing Director\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nfinnCap Ltd \n\n\nTel: 020 7220 0500\n\n\n\n\nGeoff Nash/Christopher Raggett (Corporate Finance)\n\n\n\n\n\n\n\nStephen Norcross/Mia Gardner (Corporate Broking)\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nWalbrook PR Limited \n\n\nTel: 020 7933 8780 or [email protected]\n\n\n\n\nPaul McManus\n\n\nMob: 07980 541 893\n\n\n\n\nLianne Cawthorne\n\n\nMob: 07584 391 303 \n\n\n\n\n \n \n \n \n \n \n \n \n \n \n\nThis information is provided by RNSThe company news service from the London Stock Exchange END MSCPGUPACUPWGAP\n ","length":...